Bedaquiline
Top View
- Investigating the Mode of Action of Tuberculosis Drugs Using Hypersensitive Mutants of Mycobacterium Smegmatis
- Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
- Bedaquiline for the Treatment of Multidrug-Resistant Tuberculosis: Another Missed Opportunity?
- Failure with Acquired Resistance of an Optimised Bedaquiline-Based Treatment Regimen for Pulmonary Mycobacterium Avium Complex Disease
- Introduction of Bedaquiline for the Treatment of Multidrug-Resistant Tuberculosis at Country Level
- The Relationship Between Target-Class and the Physicochemical Properties of Antibacterial Drugs ⇑ Grace Mugumbate, John P
- SIRTURO Safely and Effectively
- Data Sheet of Clinical Trial C.T
- Large-Scale Chemical-Genetics Yields New Mycobacterium Tuberculosis Inhibitor Classes
- Identification of Whole Cell Active Molecules of Mycobacterium Tuberculosis, Elucidation of Molecular Mechanisms Responsible
- Bedaquiline and Delamanid for the Treatment of Multidrug-Resistant Tuberculosis: a Multicentre Cohort Study in Korea
- DRUG-RESISTANT TUBERCULOSIS : 63 : a SURVIVAL GUIDE for CLINICIANS : 3RD EDITION TREATMENT DRUG-RESISTANT TUBERCULOSIS Compared Todrug-Susceptibledisease
- Bedaquiline- and Delamanid- Containing Regimens Achieve Excellent Interim Treatment Response Without Safety Concerns Endtb Inter
- CONSERVING the USE of CRITICALLY IMPORTANT ANTIMICROBIALS in FOOD-PRODUCING ANIMALS Gaps and Possibilities in Global Guidance and Indian Policy Framework
- Antiinfectives Targeting Enzymes and the Proton Motive Force
- WHO Best-Practice Statement on the Off-Label Use of Bedaquiline and Delamanid for the Treatment of Multidrug-Resistant Tuberculosis
- A Review of the Bedaquiline Patent Landscape a Scoping Report
- Rapid Communication: Key Changes to Treatment of Multidrug- and Rifampicin-Resistant Tuberculosis (MDR/RR-TB)